Health Technologies

Colin Bower joins VivoSense as CEO

VivoSense, Inc. has announced the appointment of Colin Bower as CEO and a member of its Board of Directors.

Bower will succeed Dudley Tabakin, who will continue with VivoSense as Chief Product Officer.

VivoSense is an aend-to-end scientific solutions company developing novel digital endpoints from wearable sensor data.

Bower said: “I’m delighted to join the tremendously talented team at VivoSense.

“For more than a decade, they have led pharma partners and enhanced clinical research through the adoption of sensor-driven endpoints.

“By matching our new clinical measures based on machine learning with growing sponsor demand for validated digital endpoints, we will materially facilitate the path to precision care for all patients.”

Bower has than a decade of experience developing leading digital health products and bringing them to market in the roles of founder, CEO, commercial leader and director.

Bower most recently served as Chief Growth Officer at Panalgo, a machine learning RWD analytics platform, seeing it through an acquisition by MMIT, a company held jointly by Welsh, Carson, Anderson & Stowe and Hg.

Dudley Tabakin, Chief Product Officer, said:

“I am excited to welcome Colin to VivoSense.

“Colin is a proven leader with a deep understanding of the digital health technology industry.

“He has a track record of success in growing and leading businesses, and I am confident that he is the right leader to take VivoSense to the next level. Colin and I will be working together — combining our strengths to build on our company’s success in developing and delivering real-world digital clinical measures and taking the company to new heights.”

VivoSense board member, Chris Garabedian, added:

“We’re excited to have Colin join us as CEO and Director of VivoSense and drive the next phase of our development. Colin’s track record with global biopharma and biotech partners is extensive and admirable.

“He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.

“Colin has demonstrated strong leadership to his teams and customers alike.”

You may also like

Health Technologies

Accelerating Strategies Around Internet of Medical Things Devices

  • December 22, 2022
IoMT Device Integration with the Electronic Health Record Is Growing By their nature, IoMT devices are integrated into healthcare organizations’
Health Technologies

3 Health Tech Trends to Watch in 2023

Highmark Health also uses network access control technology to ensure computers are registered and allowed to join the network. The